Diamorphine
Opioid Agonist — NERVOUS SYSTEM
Also known as: acetomorphin, acetomorphine, diacetylmorphine, diacetylmorphine HCl, diacetylmorphine hydrochloride, diamorphine HCl, diamorphine hydrochloride, heroin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Diamorphine is an ofp drug in the Opioid Agonist class catalogued in DrugCentral. Its mechanism of action is classified as Full Opioid Agonists. DrugCentral lists 3 molecular targets, including Drd2, Drd3 and Drd1. Recorded indications include Severe pain.
- Approval status: ofp.
- Drug class: Opioid Agonist.
- Mechanism of action: Full Opioid Agonists.
- Molecular targets: Drd2, Drd3 and Drd1 (3 listed in DrugCentral).
- Indications: Severe pain.
- ATC code: N07BC06 (Drugs used in opioid dependence).
- Molecular formula: C21H23NO5; molecular weight 369.42 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Severe pain
Mechanism & targets
| Mechanism of action (MoA) | Full Opioid Agonists |
|---|---|
| Established pharmacologic class | Opioid Agonist |
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| D(2) dopamine receptor | Drd2 | unknown | Ki 7.96 |
| D(3) dopamine receptor | Drd3 | unknown | Ki 7.44 |
| D(1A) dopamine receptor | Drd1 | unknown | Ki 6.62 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N07BC06 | NERVOUS SYSTEM › OTHER NERVOUS SYSTEM DRUGS › DRUGS USED IN ADDICTIVE DISORDERS › Drugs used in opioid dependence |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Drug abuse | 14782.8 |
| Toxicity to various agents | 4096.7 |
| Cardio-respiratory arrest | 1129.9 |
| Drug dependence | 1086.9 |
| Respiratory arrest | 1057.3 |
| Overdose | 779.0 |
| Intentional product misuse | 716.0 |
| Cardiac arrest | 672.6 |
| Asphyxia | 562.1 |
| Substance abuse | 502.6 |
| Death | 478.6 |
| Respiratory depression | 383.0 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Diamorphine is on its molecule page.
| Molecular formula | C21H23NO5 |
|---|---|
| Molecular weight | 369.42 g/mol |
| CAS number | 561-27-3 |
| InChIKey | GVGLGOZIDCSQPN-PVHGPHFFSA-N |
| PubChem CID | 5288826 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Diamorphine used for?
DrugCentral lists the following indications for Diamorphine: Severe pain.
How does Diamorphine work?
Diamorphine is classified as Full Opioid Agonists; its molecular targets in DrugCentral include Drd2, Drd3 and Drd1.
What drug class does Diamorphine belong to?
Diamorphine is in the Opioid Agonist class.
What is the chemical formula of Diamorphine?
Diamorphine has the molecular formula C21H23NO5 and a molecular weight of 369.42 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4412 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2106627 — compound record and bioactivity
- PubChem CID 5288826 — chemical identifiers
- DrugBank DB00295 — drug record
- FDA UNII 70D95007SX — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.